Mara Patricia Chavez-Ortega

Dr. Mara Patricia Chavez-Ortega


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MCMara Patricia Chavez-Ortega
Mara Patricia Chavez-Ortega
Julio C Almanza-PerezJulio C Almanza-Perez
Julio C Almanza-Perez
Fausto Sanchez-MunozFausto Sanchez-Munoz
Fausto Sanchez-Munoz
EHEnrique Hong
Enrique Hong
EVElihu Velázquez-Reyes
Elihu Velázquez-Reyes
FHFengyang Huang
Fengyang Huang
Previous studies provided evidence of the benefits of omega-3 polyunsaturated fatty acids (ω-3 PUFA) on the cardiovascular system and inflammation. However, its possible effect on skeletal muscle is unknown. This study aimed to evaluate whether ω-3 PUFA reverses the dysregulation of metabolic modulators in the skeletal muscle of rats on a high-fat obesogenic diet. For this purpose, an animal model was developed using male Wistar rats with a high-fat diet (HFD) and subsequently supplemented with ω-3 PUFA. Insulin resistance was assessed, and gene and protein expression of metabolism modulators in skeletal muscle was also calculated using PCR-RT and Western blot. Our results confirmed that in HFD rats, zoometric parameters and insulin resistance were increased compared to SD rats. Furthermore, we demonstrate reduced gene and protein expression of peroxisome proliferator-activated receptors (PPARs) and insulin signaling molecules. After ω-3 PUFA supplementation, we observed that glucose (24.34%), triglycerides (35.78%), and HOMA-IR (40.10%) were reduced, and QUICKI (12.16%) increased compared to HFD rats. Furthermore, in skeletal muscle, we detected increased gene and protein expression of PPAR-α, PPAR-γ, insulin receptor (INSR), insulin receptor substrate 1 (ISR-1), phosphatidylinositol-3-kinase (PI3K), and glucose transporter 4 (GLUT-4). These findings suggest that ω-3 PUFAs decrease insulin resistance of obese skeletal muscle.

Verified
Journal Article
Open access
PDF file
MCMara Patricia Chavez-Ortega
Mara Patricia Chavez-Ortega
MPMario Peña Peña
Mario Peña Peña
Roxana CarboRoxana Carbo
Roxana Carbo
AMAida Medina-Urrutia
Aida Medina-Urrutia
Horacio OsorioHoracio Osorio
Horacio Osorio
FHFengyang Huang
Fengyang Huang
Adipose tissue is now recognized as a heterogeneous endocrine and metabolic organ rather than a passive lipid reservoir. Beyond the classical white, brown, and beige adipocytes, several depot- and organ-specific lipid-storing cell populations, including pink adipocytes, bone marrow (yellow) adipocytes, and hepatic stellate cells, contribute to energy homeostasis, thermogenesis, immune regulation, bone marrow function, and hepatic retinoid storage. Most existing reviews address these populations separately or focus narrowly on classical depots. Here, we integrate classical and non-classical adipocyte populations within a single depot-specific framework, examining how anatomical location and functional specialization jointly determine their contribution to obesity-related non-communicable diseases, including type 2 diabetes mellitus, metabolic-associated fatty liver disease, hypertension, and atherosclerotic cardiovascular disease. We further highlight unresolved mechanistic questions, including macrophage phenotypic heterogeneity beyond the classical M1/M2 model, the translational limits of brown adipose tissue activation, and the paracrine role of perivascular adipose tissue, that represent priority areas for future investigation.